chr18-23538609-C-G
Variant summary
Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PS1PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000271.5(NPC1):āc.2974G>Cā(p.Gly992Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000372 in 1,614,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Pathogenicin Lovd. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G992A) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPC1 | NM_000271.5 | c.2974G>C | p.Gly992Arg | missense_variant | 20/25 | ENST00000269228.10 | NP_000262.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPC1 | ENST00000269228.10 | c.2974G>C | p.Gly992Arg | missense_variant | 20/25 | 1 | NM_000271.5 | ENSP00000269228.4 | ||
NPC1 | ENST00000591051.1 | c.2050G>C | p.Gly684Arg | missense_variant | 13/18 | 2 | ENSP00000467636.1 | |||
NPC1 | ENST00000591075.1 | n.607G>C | non_coding_transcript_exon_variant | 2/3 | 4 | |||||
NPC1 | ENST00000591955.1 | n.317G>C | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251484Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135916
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461868Hom.: 0 Cov.: 32 AF XY: 0.0000426 AC XY: 31AN XY: 727230
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74500
ClinVar
Submissions by phenotype
Niemann-Pick disease, type C1 Pathogenic:6Other:1
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Jul 23, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 14, 2004 | - - |
Likely pathogenic, criteria provided, single submitter | literature only | Counsyl | May 19, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 992 of the NPC1 protein (p.Gly992Arg). This variant is present in population databases (rs80358254, gnomAD 0.02%). This missense change has been observed in individuals with Niemann-Pick disease type C (PMID: 11333381, 16126423, 26984608). ClinVar contains an entry for this variant (Variation ID: 2969). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. This variant disrupts the p.Gly992 amino acid residue in NPC1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9634529, 12955717, 16126423, 20718790). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | Jul 22, 2023 | The observed missense variant c.2974G>Cp.Gly992Arg in NPC1 gene has been reported previously in individuals with Niemann-Pick disease type C. This variant is present in a mutational hotspot. Different amino acid changes p.Gly992Ala; p.Gly992Trp affecting the same position have been reported as pathogenic Sedel F, et al., 2016; Dardis A, et al., 2020. This variant is reported with the allele frequency 0.001% in the gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic/Likely Pathogenic. The amino acid Gly at position 992 is changed to a Arg changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence Polyphen - Possibly damaging, SIFT ā Damaging and MutationTaster - Disease causing predict a damaging effect on protein structure and function for this variant. The residue is conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Likely Pathogenic. In the absence of another reportable variant, the molecular diagnosis is not confirmed. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Feb 02, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Niemann-Pick disease type C1 (MIM# 257220). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from glycine to arginine. (I) 0251 - This variant is heterozygous. (I) 0304 - This variant is present in gnomAD (v2) <0.01 for a recessive condition (14 heterozygotes, 0 homozygotes). Additionally, an alternative nucleotide change (G>A) resulting in the same amino acid substitution is also present in gnomAD (v2) (4 heterozygotes, 0 homozygotes). (SP) 0309 - Alternative amino acid changes at the same position have been observed in gnomAD (v2) (5 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants. This variant is located in a region within the cysteine-rich luminal loop where many missense variants have been reported (PMID: 16126423, PMID: 11333381). (SP) 0702 - Other missense variants comparable to the one identified in this case have strong previous evidence for pathogenicity. Two different variants in the same codon resulting in a changes to an alanine and a tryptophan have also been reported as pathogenic in patients with Niemann-Pick type C disease (ClinVar, PMID: 16126423, PMID: 32138288). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been previously reported as pathogenic in patients with Niemann-Pick type C disease. Additionally, another variant involving an alternative nucleotide change (G>A) that causes the same amino acid change has also been reported as pathogenic in patients with Niemann-Pick type C disease (ClinVar, PMID: 11333381, PMID: 32138288). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 21, 2019 | PS1, PS4, PM1, PM2, PM5 - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 25, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23821321, 23773996, 15596783, 16098014, 19307542, 28710748, 26984608, 25537619, 16126423, 24570279, 25349751, 20718790, 19609713, 19013089, 12205649, 11479732, 12955717, 26790753, 32138288, 34426522, 33360098, 31589614, 11333381, 34830064) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 25, 2017 | - - |
Niemann-Pick disease, type C Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 26, 2017 | Variant summary: The NPC1 c.2974G>C (p.Gly992Arg) variant involves the alteration of a conserved nucleotide. 2/4 in silico tools predict a damaging outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 4/121558 control chromosomes at a frequency of 0.0000329, which does not exceed the estimated maximal expected allele frequency of a pathogenic NPC1 variant (0.0027735). This variant has been reported in NPC patients (mostly adult-onset) both as homozygote and compound heterozygote. Another variant involving the same nucleotide G2974A, causing the same amino acid change G992R, has also been reported in multiple affected individuals. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic/likely pathogenic. Taken together, this variant is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at